Nephrology
Renal Protection
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Renal Protection is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Completed4 · 57%
Withdrawn1 · 14%
Recruiting1 · 14%
Terminated1 · 14%
Clinical Trials
Trial Activity
7 trials
An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery
Completed·—·Phase 2·NCT00122018·80 enrolled
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
Withdrawn·—·N/A·NCT05016440
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)